Henry Chan

Title: The Innovations of Henry Chan

Introduction

Henry Chan is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents to his name, Chan's work has implications for therapeutic and diagnostic applications.

Latest Patents

Henry Chan's latest patents focus on WAP domain fusion polypeptides and their methods of use. These inventions relate to fusion proteins that include a whey acidic protein (WAP) domain-containing polypeptide and a second polypeptide. Additionally, the patents describe fusion proteins that incorporate a WAP domain-containing polypeptide, a second polypeptide, and a third polypeptide. The second and/or third polypeptides can be a Fe polypeptide, an albumin polypeptide, a cytokine targeting polypeptide, or a serpin polypeptide. The inventions also encompass methods for utilizing these molecules in various therapeutic and diagnostic contexts, as well as methods for producing them.

Career Highlights

Henry Chan is currently associated with Inhibrx, Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential to advance medical treatments and diagnostics.

Collaborations

Chan collaborates with esteemed colleagues such as John C. Timmer and Brendan P. Eckelman. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Henry Chan's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic and diagnostic applications.